import streamlit as st
import pandas as pd
import time
import io
import google.generativeai as genai

def analyze_with_gemini(df, gemini_api_key, product_name, user_prompt):
    """Gemini AIë¥¼ ì‚¬ìš©í•œ ë…¼ë¬¸ ë¶„ì„"""
    genai.configure(api_key=gemini_api_key)
    model = genai.GenerativeModel('gemini-2.0-flash-exp')
    df_copy = df.copy()

    progress_bar = st.progress(0)
    status_text = st.empty()

    with st.spinner("ğŸ¤– AI ë¶„ì„ ì¤‘..."):
        for idx, row in df_copy.iterrows():
            progress = (idx + 1) / len(df_copy)
            progress_bar.progress(progress)
            status_text.text(f"ì²˜ë¦¬ ì¤‘... {idx + 1}/{len(df_copy)}")

            # ì œí’ˆëª…ì´ ì œëª©ì´ë‚˜ ì´ˆë¡ì— í¬í•¨ë˜ëŠ”ì§€ í™•ì¸
            if (product_name.lower() in str(row['Title']).lower() or 
                product_name.lower() in str(row['Abstract']).lower()):
                df_copy.at[idx, 'Select'] = 'Y'

                # Geminië¡œ ì´ìœ  ìƒì„±
                prompt = user_prompt.format(
                    title=str(row['Title'])[:300],
                    abstract=str(row['Abstract'])[:1000],
                    product=product_name
                )
                try:
                    response = model.generate_content(prompt)
                    if response and response.text:
                        df_copy.at[idx, 'Reason'] = response.text.strip()
                    else:
                        df_copy.at[idx, 'Reason'] = "ì‘ë‹µ ì—†ìŒ"
                except Exception as e:
                    df_copy.at[idx, 'Reason'] = f"Gemini ì˜¤ë¥˜: {e}"
            else: 
                df_copy.at[idx, 'Select'] = ''
                df_copy.at[idx, 'Reason'] = ''

            # API ìš”ì²­ ì œí•œ
            time.sleep(0.5)

    progress_bar.empty()
    status_text.empty()

    # ê²°ê³¼ ì €ì¥ ë° í‘œì‹œ
    st.session_state.df = df_copy
    st.success("âœ… AI ë¶„ì„ ì™„ë£Œ!")

    selected_count = len(df_copy[df_copy['Select'] == 'Y'])
    st.info(f"ğŸ“Š ì „ì²´ {len(df_copy)}ê°œ ì¤‘ {selected_count}ê°œê°€ ê´€ë ¨ ìˆìŒìœ¼ë¡œ ë¶„ì„")

    st.dataframe(df_copy, use_container_width=True)

    # ê²°ê³¼ ë‹¤ìš´ë¡œë“œ
    excel_bytes = io.BytesIO()
    df_copy.to_excel(excel_bytes, index=False, engine='openpyxl')
    st.download_button(
        label="ğŸ“¥ ë¶„ì„ ê²°ê³¼ ë‹¤ìš´ë¡œë“œ",
        data=excel_bytes.getvalue(),
        file_name=f"gemini_analysis_{pd.Timestamp.now().strftime('%Y%m%d_%H%M%S')}.xlsx",
        mime="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
        use_container_width=True
    )

def get_meddev_analysis_prompt(text, product_name):
    """MEDDEV 2.7/1 Rev. 4 ë¶„ì„ í”„ë¡¬í”„íŠ¸"""
    return f"""
ì•„ë˜ëŠ” ì˜ë£Œê¸°ê¸° ì„ìƒ ë…¼ë¬¸ì˜ ë³¸ë¬¸ì…ë‹ˆë‹¤.

ë¶„ì„ ëŒ€ìƒ ê¸°ê¸°ëª…: {product_name}

1. ë…¼ë¬¸ ì „ì²´ì— ëŒ€í•œ í‰ê°€(ë°©ë²•ë¡ , ì¼ë°˜ì  ê´€ë ¨ì„±, ê¸°ì—¬ë„, ì¢…í•©í‰ê°€)ëŠ” ë…¼ë¬¸ ìì²´ ê¸°ì¤€ìœ¼ë¡œ MEDDEV 2.7/1 Rev.4ì— ë”°ë¼ ë¶„ì„í•˜ì„¸ìš”.
2. ë‹¨, 'STEP 3: Relevance Suitability' í‘œë§Œ '{product_name}'(ìš°ë¦¬ ê¸°ê¸°)ì™€ì˜ ì í•©ì„±/ê´€ë ¨ì„± ê¸°ì¤€ìœ¼ë¡œ ë¶„ì„í•˜ì„¸ìš”.
**All Remarks, Comments, and explanations in the tables must be written in English.**

ë…¼ë¬¸ ë‚´ìš©:
{text[:10000]}

ë‹¤ìŒ í˜•ì‹ìœ¼ë¡œ ë¶„ì„í•´ì£¼ì„¸ìš”:

## ë…¼ë¬¸ ì •ë³´
Title: [ë…¼ë¬¸ ì œëª©]
Authors: [ì €ì]
Journal: [ì €ë„ëª…]
Publication Year: [ë°œí–‰ë…„ë„]
Study Type: [ì—°êµ¬ ìœ í˜•]

## ê¸°ê¸° ì •ë³´  
Device Name: [ì˜ë£Œê¸°ê¸°ëª…]
Company: [ì œì¡°íšŒì‚¬]

## STEP 2: Methodological Appraisal
METHODOLOGICAL_TABLE_START
| Aspects covered | Weight | Remarks |
|-----------------|--------|---------|
| Information on elementary aspects | Adequate (2) / Non adequate (1) | [í‰ê°€ ë‚´ìš©] |
| Patients number | High (2) / Medium (1) / Poor (0) | [í‰ê°€ ë‚´ìš©] |
| Statistical method(s) | Adequate (2) / Non adequate (1) | [í‰ê°€ ë‚´ìš©] |
| Adequate controls | Adequate (2) / Non adequate (1) | [í‰ê°€ ë‚´ìš©] |
| Collection of mortality and serious adverse events data | Adequate (2) / Non adequate (1) | [í‰ê°€ ë‚´ìš©] |
| Interpretation of the authors | Good (1) / Misinterpretation (0) | [í‰ê°€ ë‚´ìš©] |
| Study legality | Legal (1) / Illegal (0) | [í‰ê°€ ë‚´ìš©] |
| Total | [ì´ì ] (10-12: Excellent, 8-9: Very Good, 6-7: Good, 0-5: Poor) | [ì¢…í•© í‰ê°€] |
METHODOLOGICAL_TABLE_END

# ...existing code...

## STEP 3: Relevance Appraisal  
RELEVANCE_TABLE_START
| Description | Examples | V | Comment |
|-------------|----------|---|---------|
# ...existing code...

| To what extent are the data generated from the device under evaluation representative of the device under evaluation? | Device under evaluation | [ ] | |
| | Equivalent device | [ ] | |
| | Benchmark device | [ ] | |
| | Other devices and medical alternatives | [ ] | |
| | Data concerning the medical conditions that are managed with the device | [ ] | |
| What aspects are covered? | Pivotal performance data | [ ] | |
| | Pivotal safety data | [ ] | |
| | Claims | [ ] | |
| | Identification of hazards | [ ] | |
| | Estimation and management of risks | [ ] | |
| | Enhancement of current knowledge / the state of the art | [ ] | |
| | Determination and justification of criteria for the evaluation of the risk/benefit relationship | [ ] | |
| | Determination and justification of criteria for the evaluation of acceptability of undesirable side-effects | [ ] | |
| | Determination of equivalence | [ ] | |
| | Justification of the validity of surrogate endpoints | [ ] | |
| Are the data relevant to the intended purpose of the device or to claims about the device? | Representative of the entire intended purpose for all patient populations and all claims foreseen for the device under evaluation | [ ] | |
| | Concerns specific models/sizes/settings, or concerns specific aspects of the intended purpose or of claims | [ ] | |
| | Does not concern the intended purpose or claims | [ ] | |
| - Model, size, or settings of the device | Smallest / intermediate / largest size | [ ] | |
| | Lowest / intermediate / highest dose | [ ] | |
| | Etc. | [ ] | |
| - User group | Specialists | [ ] | |
| | General practitioners | [ ] | |
| | Nurses | [ ] | |
| | Adult healthy lay persons | [ ] | |
| | Disabled persons | [ ] | |
| | Children | [ ] | |
| | Etc. | [ ] | |
| - Medical indication (if applicable) | Migraine prophylaxis | [ ] | |
| | Treatment of acute migraine | [ ] | |
| | Rehabilitation after stroke | [ ] | |
| | Etc. | [ ] | |
| - Age group | pre-term infants / neonates / children / adolescents / adults / old age | [ ] | |
| - Gender | Female / male | [ ] | |
| - Type and severity of the medical condition | Early / late stage | [ ] | |
| | Mild / intermediate / serious form | [ ] | |
| | Acute / chronic phase | [ ] | |
| | Etc. | [ ] | |
| - Range of time | Duration of application or use | [ ] | |
| | Number of repeat exposures | [ ] | |
| | Duration of follow-up | [ ] | |
RELEVANCE_TABLE_END

## STEP 3: Relevance Appraisal (Suitability)
RELEVANCE_SUITABILITY_TABLE_START
| Suitability Criteria: Description | Weight | Description |
|-----------------------------------|--------|-------------|
| Appropriate Device: Were the data generated from the device in question? | 2 / 1 | Actual device / Comparable device |
| Appropriate device application: Was the device used for the same intended use (e.g., methods of deployment, application, etc.)? | 3 / 2 / 1 | Same use / Minor deviation / Major deviation |
| Appropriate patient group: Was the data generated from a patient group that is representative of the intended treatment population (e.g., age, sex, etc.) and clinical condition (i.e., disease, including state and severity)? | 3 / 2 / 1 | Applicable / Limited / Different population |
| Acceptable report/data collation: Do the reports or collations of data contain sufficient information to be able to undertake a rational and objective assessment? | 3 / 2 / 1 | High quality / Minor deficiencies / Insufficient information |
| Total | 10 to 11 | Excellent |
| | 8 to 9 | Very Good |
| | 6 to 7 | Good |
| | 0 to 5 | Poor |
RELEVANCE_SUITABILITY_TABLE_END


## Acceptance criteria: 
The total Methodological result should be Very Good or Excellent.

## STEP 4: Contribution Appraisal
CONTRIBUTION_TABLE_START
| Contribution Criteria: Description | Weight | Remarks |
|------------------------------------|--------|---------|
| Data source type / Was the design of the study appropriate? | Yes (2) / No (1) | [í‰ê°€ ë‚´ìš©] |
| Outcome measures: Does the outcome measures reported reflect the intended performance of the device? | Yes (2) / No (1) | [í‰ê°€ ë‚´ìš©] |
| Follow up: Long enough to assess whether duration of treatment effects and identify complications? | Yes (2) / No (1) | [í‰ê°€ ë‚´ìš©] |
| Statistical significance: Has a statistical analysis of the data been provided and is it appropriate? | Yes (2) / No (1) | [í‰ê°€ ë‚´ìš©] |
| Clinical significance: Was the magnitude of the treatment effect observed clinically significant? | Yes (2) / No (1) | [í‰ê°€ ë‚´ìš©] |
| Total | | 9 to 10: Excellent / 7 to 8: Very Good / 5 to 6: Good / 0 to 4: Poor |
CONTRIBUTION_TABLE_END


# ...existing code...

## STEP 5: Overall Assessment
OVERALL_TABLE_START
| Appraisal Summary | Weight | Results | Overall appraisal |
|-------------------|--------|---------|------------------|
| Methodological | [ì ìˆ˜] / 12 | [í‰ê°€ë“±ê¸‰] | |
| Relevance | [ì ìˆ˜] / 11 | [í‰ê°€ë“±ê¸‰] | [ì´ì ] / 33 |
| Contribution | [ì ìˆ˜] / 10 | [í‰ê°€ë“±ê¸‰] | |
OVERALL_TABLE_END

## Acceptance Criteria
The overall result should be Very Good or Excellent.

## ê²°ë¡ 
[ì¢…í•© í‰ê°€ ë° ê¶Œì¥ì‚¬í•­]

ìœ„ í˜•ì‹ì„ ì •í™•íˆ ë”°ë¼ ë¶„ì„í•´ì£¼ì„¸ìš”. í‘œ êµ¬ë¶„ì(TABLE_START/TABLE_END)ë¥¼ ë°˜ë“œì‹œ í¬í•¨í•´ì£¼ì„¸ìš”.
"""
